Author:
Ivy S. Percy,Egorin Merrill J.,Takimoto Chris H.,Wick Jeannette Y.
Reference92 articles.
1. Donelli MG, Zucchetti M, Munzone E, et al. Pharmacokinetics of anticancer agents in patients with impaired liver function. Eur J Cancer. 1998;34:33–46.
2. Takimoto CH, Mita AC. Design, conduct, and interpretation of organ impairment studies in oncology patients. J Clin Oncol. 2006;24:3509–10.
3. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Available at http://www.kidney.org/Professionals/Kdoqi/guidelines_ckd/toc.htm . Accessed October 20, 2008.
4. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1–12.
5. Lee WM, Seremba E. Etiologies of acute liver failure. Curr Opin Crit Care. 2008; 14:198–201.